FSH-FSHR3-stem cells in ovary surface epithelium: Basis for adult ovarian biology, failure, aging, and cancer

Reproduction

Volumn 149, Issue 1, 2015, Pages R35-R48

  Bhartiya, Deepa ^a   Singh, Jarnail ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; FOLLITROPIN; FOLLITROPIN RECEPTOR; FOLLITROPIN RECEPTOR 3; LIN28 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RECOMBINANT FOLLITROPIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AZOOSPERMIA; CANCER PATIENT; CANCER STEM CELL; CELL AGING; CELL INTERACTION; CELLS BY BODY ANATOMY; CYTOLOGY; EPITHELIUM; EPITHELIUM CELL; FEMALE FERTILITY; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; OVARY CELL; OVARY FOLLICLE; OVARY SURFACE EPITHELIUM; PREMATURE OVARIAN FAILURE; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STEM CELL; TESTIS; ADULT; AGING; FEMALE; GENETICS; METABOLISM; MUTATION; OVARY; OVARY TUMOR; PATHOLOGY;

ADULT; AGING; EPITHELIUM; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; MUTATION; OVARIAN NEOPLASMS; OVARY; PRIMARY OVARIAN INSUFFICIENCY; RECEPTORS, FSH; STEM CELLS;

EID: 84920562229     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-14-0220     Document Type: Review

References (111)

1. Abbott A 2013 Doubt cast over tiny stem cells. Nature 499 390. (doi:10.1038/499390a)
2. Abd-Elaziz M, Moriya T, Akahira J., Suzuki T & Sasano H 2005 StAR and progesterone producing enzymes (3b-hydroxysteroid dehydrogenase and cholesterol side-chain cleavage cytochromes P450) in human epithelial ovarian carcinoma: immunohistochemical and real-time PCR studies. Cancer Science 96 232-239. (doi:10.1111/j.1349-7006.2005.00040.x)
3. Achrekar SK, Modi DN, Meherji P.K., Patel ZM & Mahale SD 2010 Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea. Journal of Assisted Reproduction and Genetics 27 317-326. (doi:10.1007/s10815-010-9404-9)
4. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P., Tapanainen J, Gromoll J, Kaskikari R., Sankila EM, Lehvaslaiho H, Engel AR et al. 1995 Mutation in the follicle-stimulating hormone receptor gene causes hereditary hyper gonadotropic ovarian failure. Cell 82 959-968. (doi:10.1016/0092-8674(95)90275-9)
5. Allen LA, Achermann JC, Pakarinen P, Kotlar T.J., Huhtaniemi IT, Jameson JL, Cheetham TD & Ball SG 2003 A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonado-trophic hypogonadism: clinical and molecular characteristics. Human Reproduction 18 251-256. (doi:10.1093/humrep/deg046)
6. Anand S, Bhartiya D, Sriraman K., Patel H & Manjramkar DD 2014 Very small embryonic-like stem cells survive and can restore spermatogenesis after busulphan treatment in mouse testis. Journal of Stem Cell Research & Therapy 4 7. (doi:10.4172/2157-7633.1000216)
7. Auersperg N 2013 The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae. International Journal of Gynecological Pathology 32 444-453. (doi:10.1097/PGP.0b013e3182800ad5)
8. Babu PS, Jiang L, Sairam A.M., Touyz RM & Sairam MR 1999 Structural features and expression of an alternatively spliced growth factor type I receptor for follitropin signaling in the developing ovary. Molecular Cell Biology Research Communications 2 21-27. (doi:10.1006/mcbr.1999.0139)
9. Babu PS, Krishnamurthy H, Chedrese PJ & Sairam MR 2000 Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor. Role in hormone signaling and cell proliferation. Journal of Biological Chemistry 275 27615-27626. (doi:10.1074/jbc.M003206200)
10. Babu PS, Danilovich N & Sairam MR 2001 Hormone-induced receptor gene splicing: enhanced expression of the growth factor type I follicle-stimulating hormone receptor motif in the developing mouse ovary as a new paradigm in growth regulation. Endocrinology 142 381-389. (doi:10.1210/endo.142.1.7886)
11. Bas F, Pescovitz OH & Steinmetz R 2009 No activating mutations of FSH receptor in four children with ovarian juvenile granulose cell tumors and the association of these tumors with central precocious puberty. Journal of Pediatric and Adolescent Gynecology 22 173-179. (doi:10.1016/j.jpag.2008.10.003)
12. Beau I, Touraine P, Meduri G., Gougeon A, Desroches A, Matuchansky C., Milgrom E, Kuttenn F & Misrahi M 1998 A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. Journal of Clinical Investigation 102 1352-1359. (doi:10.1172/JCI3795)
13. Bhartiya D 2012 The continued presence of stem cells and oogonia in the adult mammalian ovary. Human Reproduction 27 938. (doi:10.1093/humrep/der423)
14. Bhartiya D, Kasiviswanathan S, Unni S.K., Pethe P., Dhabalia JV, Patwardhan S & Tongaonkar HB 2010 Newer insights into premeiotic development of germ cells in adult human testis using Oct-4 as a stem cell marker. Journal of Histochemistry and Cytochemistry 58 1093-1106. (doi:10.1369/jhc.2010.956870)
15. Bhartiya D, Sriraman K, Gunjal P & Modak H 2012 Gonadotropin treatment augments postnatal oogenesis and primordial follicle assembly in adult mouse ovaries? Journal of Ovarian Research 5 32. (doi:10.1186/1757-2215-5-32)
16. Bhartiya D, Sriraman K, Parte S & Patel H 2013a Ovarian stem cells: absence of evidence is not evidence of absence. Journal of Ovarian Research 6 65. (doi:10.1186/1757-2215-6-65)
17. Bhartiya D, Unni S, Parte S & Anand S 2013b Very small embryonic-like stem: implications in reproductive biology. BioMed Research International 2013 682326. (doi:10.1155/2013/682326)
18. Bhartiya D, Sriraman K, Bhutda S., Mundekar AS, Mulla S & Modak H 2013c Neonatal exposure to estrogen affects very small ES-like stem cells (VSELs) leading to various pathologies in adults including cancer. Journal of Cancer Stem Cell Research 1 e1003. (doi:10.14343/JCSCR.2013.1e1003)
19. Blaakaer J, Baeksted M, Micic S., Albrectsen P, Rygaard J & Bock J 1995 Gonadotropin releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype. Biology of Reproduction 53 775-779. (doi:10.1095/biolreprod53.4.775)
20. Bose CK 2005 Role of nerve growth factor, follicle stimulating hormone receptor and epithelial ovarian cancer. Reproductive Biomedicine Online 11 194-197. (doi:10.1016/S1472-6483(10)60958-3)
21. Bose CK 2008 Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer. Oncology Research 17 231-238. (doi:10.3727/096504008786111383)
22. Bukovsky A 2011 How can female germline stem cells contribute to the physiological neo-oogenesis in mammals and why menopause occurs? Microscopy and Microanalysis 17 498-505. (doi:10.1017/S143192761000036X)
23. Burdett JE, Kurley SJ, Kilen S.M., Mayo KE & Woodruff TK 2006 Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice. Endocrinology 147 2338-2345. (doi:10.1210/en.2005-1629)
24. Chakkalakal JV, Jones KM, Basson MA & Brack AS 2012 The aged niche disrupts muscle stem cell quiescence. Nature 490 355-360. (doi:10.1038/nature11438)
25. Chen X, Aravindakshan J, Yang Y & Sairam MR 2007 Early alterations in OSE and induction of ovarian epithelial tumors triggered by loss of FSHR. Neoplasia 9 521-531. (doi:10.1593/neo.07238)
26. de la Chesnaye E, Canto P, Ulloa-Aguirre A & Méndez JP 2001 No evidence of mutations in the follicle-stimulating hormone receptor gene in Mexican women with 46,XX pure gonadal dysgenesis. American Journal of Medical Genetics 98 125-128. (doi:10.1002/1096-8628(20010115)98:2<125::AID-AJMG1020>3.0.CO;2-I)
27. Choi KC, Kang SK, Tai C.J., Auersperg N & Leung PC 2002 Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells. Journal of Clinical Endocrinology and Metabolism 87 2245-2253. (doi:10.1210/jcem.87.5.8506)
28. Choi JH, Choi KC, Auersperg N & Leung PC 2004 Overexpression offollicle stimulating hormone receptor activates oncogenic pathways in preneo-plastic ovarian surface epithelial cells. Journal of Clinical Endocrinology and Metabolism 89 5508-5516. (doi:10.1210/jc.2004-0044)
29. Choi JH, Choi KC, Auersperg N & Leung PC 2005 Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase I human ovarian surface epithelial cells. Endocrine-Related Cancer 12 407-421. (doi:10.1677/erc.1.00896)
30. Conway GS, Conway E, Walker C., Hoppner W, Gromoll J & Simoni M 1999 Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clinical Endocrinology 51 97-99. (doi:10.1046/j.1365-2265.1999.00745.x)
31. Danilovich N, Roy I & Sairam MR 2001 Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology 142 3673-3684. (doi:10.1210/endo.142.8.8320)
32. Davies BR, Finnigan DS, Smith SK & Ponder BA 1999 Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium. Gynecological Endocrinology 13 75-81. (doi:10.3109/09513599909167536)
33. Dierich A, Sairam MR, Monaco L, Fimia G.M., Gansmuller A., LeMeur M & Sassone-Corsi P 1998 Impairing FSH signalling in vivo: targeted disruption of FSHR leads to aberrant gametogenesis and hormonal imbalance. PNAS 95 13612-13617. (doi:10.1073/pnas.95.23.13612)
34. Doherty E, Pakarinen P, Tiitinen A., Kiilavuori A, Huhtaniemi I, Forrest S & Aittomäki K 2002 A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. Journal of Clinical Endocrinology and Metabolism 87 1151-1155. (doi:10.1210/jcem.87.3.8319)
35. Fathalla MF 1971 Incessant ovulation - a factor in ovarian neoplasia? Lancet 2 163. (doi:10.1016/S0140-6736(71)92335-X)
36. Flesken-Nikitin A, Hwang CI, Cheng C.Y., Michurina TV, Enikolopov G & Nikitin AY 2013 Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 495 241-245. (doi:10.1038/nature11979)
37. Gaytan M, Sanchez MA, Morales C, Bellido C., Millan Y, Martín de Las Mulas J, Sánchez-Criado JE & Gaytán F 2005 Cyclic changes of the ovarian surface epithelium in the rat. Reproduction 129 311-321. (doi:10.1530/rep.1.00401)
38. Hilliard TS, Modi DA & Burdette JE 2013 Gonadotropinsactivate oncogenic pathways to enhance proliferation in normal mouse ovarian surface epithelium. International Journal of Molecular Sciences 14 4762-4782. (doi:10.3390/ijms14034762)
39. Huhtaniemi IT & Themmen AP 2005 Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 26 207-217. (doi:10.1385/ENDO:26:3:207)
40. Ji Q, Liu PI, Chen PK & Aoyama C 2004 Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells. International Journal of Cancer 112 803-814. (doi:10.1002/ijc.20478)
41. Jiang M, Aittomaki K, Nilsson C., Pakarinen P, Iitia A, Torresani T., Simonsen H, Goh V, Pettersson K, de la Chapelle A et al. 1998 The frequency of an inactivating point mutation (566C→T) of the human follicle stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. Journal of Clinical Endocrinology and Metabolism 83 4338-4343. (doi:10.1210/jcem.83.12.5306)
42. Johnson J, Canning J, Kaneko T., Pru JK & Tilly JL 2004 Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428 145-150. (doi:10.1038/nature02316)
43. Jones TD, Ulbright TM, Eble JN & Cheng L 2004 OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clinical Cancer Research 10 8544-8547. (doi:10.1158/1078-0432.CCR-04-0688)
44. Karst AM, Levanon K & Drapkin R 2011 Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. PNAS 108 7547-7552. (doi:10.1073/pnas.1017300108)
45. Khan H, Yarney TA & Sairam MR 1993 Cloning of alternatively spliced mRNA transcripts coding for variants of ovine testicular follitropin receptor lacking the G protein coupling domains. Biochemical and Biophysical Research Communications 190 888-894. (doi:10.1006/bbrc.1993.1132)
46. Kuechler A, Hauffa BP, Koninger A, Kleinau G., Albrecht B, Horsthemke B & Gromoll J 2010 An unbalanced translocation unmasks a recessive mutation in the follicle-stimulating hormone receptor (FSHR) gene and causes FSH resistance. European Journal of Human Genetics 18 656-661. (doi:10.1038/ejhg.2009.244)
47. Layman LC, Amde S, Cohen D.P., Jin M & Xie J 1998 The Finnish follicle stimulating hormone receptor (FSHR) gene mutation in women with 46,XX ovarian failure is rare in the United States. Fertility and Sterility 69 300-302. (doi:10.1016/S0015-0282(97)00480-9)
48. Li Y, Ganta S, Cheng C., Craig R, Ganta RR & Freeman LC 2007 FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor. Molecular and Cellular Endocrinology 267 26-37. (doi:10.1016/j.mce.2006.11.010)
49. Ma W, Ma J, Xu J., Qiao C, Branscum A, Cardenas A., Baron AT, Schwartz P, Maihle NJ & Huang Y 2013 Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment. Cell Cycle 12 88-97. (doi:10.4161/cc.23028)
50. Massasa E, Costa XS & Taylor HS 2010 Failure of the stem cell niche rather than loss of oocyte stem cells in the aging ovary. Aging 2 1-2.
51. Meduri G, Charnaux N, Driancourt M.A., Combettes L., Granet P, Vannier B, Loosfelt H & Milgrom E 2002 Follicle-stimulating hormone receptors in oocytes. Journal of Clinical Endocrinology and Metabolism 87 2266-2276. (doi:10.1210/jcem.87.5.8502)
52. Meduri G, Touraine P, Beau I., Lahuna O, Desroches A, Vacher-Lavenu MC, Kuttenn F & Misrahi M 2003 Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. Journal of Clinical Endocrinology and Metabolism 88 3491-3498. (doi:10.1210/jc.2003-030217)
53. Mertens-Walker I, Bolitho C, Baxter RC & Marsh DJ 2010 Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase Cd. Endocrine-Related Cancer 8 335-349. (doi:10.1677/ERC-09-0152)
54. Mertens-Walker I, Baxter RC & Marsh DJ 2012 Gonadotropin signalling in epithelial ovarian cancer. Cancer Letters 324 152-159. (doi:10.1016/j.canlet.2012.05.017)
55. v genotype. Cancer Research 33 721-723. (doi:10.1.1.325.866)
56. Niikura Y, Niikura T & Tilly JL 2009 Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment. Aging 1 971-978. (doi:10.1016/j.diff.2010.01.001)
57. Oatley JM & Brinster RL 2012 The germline stem cell niche unit in mammalian testes. Physiological Reviews 92 577-595. (doi:10.1152/physrev.00025.2011)
58. Parrott JA, Doraiswamy V, Kim G., Mosher R & Skinner MK 2001 Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Molecular and Cellular Endocrinology 172 213-222. (doi:10.1016/S0303-7207(00)00340-3)
59. Parte S, Bhartiya D, Telang J., Daithankar V, Salvi V, Zaveri K & Hinduja I 2011 Detection, characterization, and spontaneous differentiation in vitro of very small embryonic-like putative stem cells in adult mammalian ovary. Stem Cells and Development 20 1451-1464. (doi:10.1089/scd.2010.0461)
60. Parte S, Bhartiya D, Manjramkar D.D., Chauhan A & Joshi A 2013 Stimulation of ovarian stem cells by follicle stimulating hormone and basic fibroblast growth factor during cortical tissue culture. Journal of Ovarian Research 6 20. (doi:10.1186/1757-2215-6-20)
61. Parte S, Bhartiya D, Patel H., Daithankar V, Chauhan A, Zaveri K & Hinduja I 2014 Dynamics associated with spontaneous differentiation of ovarian stem cells in vitro. Journal of Ovarian Research 7 25. (doi:10.1186/1757-2215-7-25)
62. Patel H, Bhartiya D, Parte S., Gunjal P & Bhatt M 2013 FSH stimulates ovarian stem cells via alternately spliced receptor variant (FSH-R3) to induce postnatal oogenesis. Journal of Ovarian Research 6 52. (doi:10.1186/1757-2215-6-52)
63. Peng S, Maihle NJ & Huang Y 2010 Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29 2153-2159. (doi:10.1038/onc.2009.500)
64. Qin Y, Zhao H, Xu J., Shi Y, Li Z, Qiao J., Liu J, Qin C, Ren C, Li J et al. 2012 Association of 8q22.3 locus in Chinese Han with idiopathic premature ovarian failure (POF). Human Molecular Genetics 21 430-436. (doi:10.1093/hmg/ddr462)
65. Radu A, Pichon C, Camparo P., Antoine M, Allory Y, Couvelard A., Fromont G, Vu Hai MT & Ghinea N 2010 Expression of follicle-stimulating hormone receptor in tumor blood vessels. New England Journal of Medicine 363 1621-1630. (doi:10.1056/NEJMoa1001283)
66. Ratajczak MZ, Shin DM, Liu R, Marlicz W., Tarnowski M, Ratajczak J & Kucia M 2010 Epiblast/germ line hypothesis of cancer development revisited: lesson from the presence of Oct-4C cells in adult tissues. Stem Cell Reviews 6 307-316. (doi:10.1007/s12015-010-9143-4)
67. Ratajczak J, Wysoczynski M, Zuba-Surma E, Wan W., Kucia M, Yoder MC & Ratajczak MZ 2011 Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells. Experimental Hematology 39 225-237. (doi:10.1016/j.exphem.2010.10.007)
68. Ratajczak MZ, Zuba-Surma E, Wojakowski W., Suszynska M, Mierzejewska K, Liu R., Ratajczak J, Shin DM & Kucia M 2014 Very small embryonic-like stem cells (VSELs) represent a real challenge in stem cell biology: recent pros and cons in the midst of a lively debate. Leukemia 28 473-484. (doi:10.1038/leu.2013.255)
69. Renner M, Goeppert B, Siraj M.A., Radu A., Penzel R, Wardelmann E, Lehner B., Ulrich A, Stenzinger A, Warth A et al. 2013 Follicle-stimulating hormone receptor expression in soft tissue sarcomas. Histopathology 63 29-35. (doi:10.1111/his.12135)
70. Sairam MR & Babu PS 2007 The tale of follitropin receptor diversity: a recipe for fine tuning gonadal responses? Molecular and Cellular Endocrinology 260-262 163-171. (doi:10.1016/j.mce.205.11.052)
71. Sairam MR & Subbarayan VS 1997 Characterization of the 5' flanking region and potential control elements of the ovine follitropin receptor gene. Molecular Reproduction and Development 48 480-487. (doi:10.1002/(SICI)1098-2795(199712)48:4<480::AID-MRD8>3.0.CO;2-M)
72. Sairam MR, Jiang LG, Yarney TA & Khan H 1997 Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor: implications for pleiotropic actions of the hormone. Molecular Reproduction and Development 48 471-479. (doi:10.1002/(SICI)1098-2795(199712)48:4<471::AID-MRD7>3.0.CO;2-N)
73. Samardzija C, Quinn M, Findlay JK & Ahmed N 2012 Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. Journal of Ovarian Research 5 37. (doi:10.1186/1757-2215-5-37)
74. Schiffenbauer YS, Abramovitch R, Meir G., Nevo N, Holzinger M, Itin A., Keshet E & Neeman M 1997 Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. PNAS 94 13203-13208. (doi:10.1073/pnas.94.24.13203)
75. Schildkraut JM, Cooper GS, Halabi S, Calingaert B., Hartge P & Whittemore AS 2001 Age at natural menopause and the risk of epithelial ovarian cancer. Obstetrics and Gynecology 98 85-90. (doi:10.1016/S0029-7844(01)01388-6)
76. Siegel ET, Kim HG, Nishimoto HK & Layman LC 2013 The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reproductive Sciences 20 211-233. (doi:10.1177/1933719112461184)
77. Simpson JL 2008 Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Annals of the New York Academy of Sciences 1135 146-154. (doi:10.1196/annals.1429.019)
78. Simpson JL 2013 Genetics of premature ovarian failure. In Transforming Reproductive Medicine Worldwide Proceedings of 69th Annual Meeting of the American Society for Reproductive Medicine, Boston, USA, Eds BC Tarlatzis & SE Bulun. ASRM, Alabama: USA.
79. Singavarapu R, Buchinsky N, Cheon DJ & Orsulic S 2010 Whole ovary immunohistochemistry for monitoring cell proliferation and ovulatory wound repair in the mouse. Reproductive Biology and Endocrinology 8 98. (doi:10.1186/1477-7827-8-98)
80. Siraj A, Desestret V, Antoine M., Fromont G, Huerre M, Sanson M., Camparo P, Pichon C, Planeix F, Gonin J et al. 2013 Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. BMC Cancer 13 246. (doi:10.1186/1471-2407-13-246)
81. Smith ER & Xu XX 2008 Ovarian ageing, follicle depletion, and cancer: a hypothesis for the aetiology of epithelialn ovarian cancer involving follicle depletion. Lancet Oncology 9 1108-1111. (doi:10.1016/S1470-2045(08)70281-X)
82. Stadel BV 1975 Letter: the etiology and prevention of ovarian cancer. American Journal of Obstetrics and Gynecology 123 772-774. (doi:10.1210/endo.142.8.8320?ck=nck)
83. Stewart SL, Querec TD, Gruver B.N., O'Hare B, Babb JS & Patriotis C 2004 Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium. Journal of Cellular Physiology 198 119-124. (doi:10.1002/jcp.10401)
84. Sullivan RR, Faris BR, Eborn D, Grieger D.M., Cino-Ozuna AG & Rozell TG 2013 Follicular expression of follicle stimulating hormone receptor variants in the ewe. Reproductive Biology and Endocrinology 11 113. (doi:10.1186/1477-7827-11-113)
85. Sundblad V, Chiauzzi VA, Escobar M.E., Dain L & Charreau EH 2004 Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Molecular and Cellular Endocrinology 222 53-59. (doi:10.1016/j.mce.2004.05.002)
86. Syed V, Ulinski G, Mok S.C., Yiu GK & Ho SM 2001 Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Researchf 61 6768-6776.
87. Szotek PP, Chang HL, Brennand K, Fujino A., Pieretti-Vanmarcke R, Lo Celso C, Dombkowski D, Preffer F., Cohen KS, Teixeira J et al. 2008 Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. PNAS 105 12469-12473. (doi:10.1073/pnas.0805012105)
88. Takakura K, Takebayashi K, Wang H.Q., Kimura F., Kasahara K & Noda Y 2001 Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome. Fertility and Sterility 75 207-209. (doi:10.1016/S0015-0282(00)01673-3)
89. Tan OL & Fleming JS 2004 Proliferating cell nuclear antigen immuno-reactivity in the ovarian surface epithelium of mice of varying ages and total lifetime ovulation number following ovulation. Biology of Reproduction 71 1501-1507. (doi:10.1095/biolreprod.104.030460)
90. Themmen AP 2005 An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 130 263-274. (doi:10.1530/rep.1.00663)
91. Themmen APN & Huhtaniemi I 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews 21 551-583. (doi:10.1210/edrv.21.5.0409)
92. Tilly JL & Telfer EE 2009 Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock? Molecular Human Reproduction 15 393-398. (doi:10.1093/molehr/gap036)
93. Touraine P, Beau I, Gougeon A., Meduri G, Desroches A, Pichard C., Detoeuf M, Paniel B, Prieur M, Zorn JR et al. 1999 New natural inactivating mutations of the follicle-stimulating hormone receptor: correlation between receptor function and phenotype. Molecular Endocrinology 13 1844-1854. (doi:10.1210/mend.13.11.0370)
94. Touyz RM, Jiang L & Sairam MR 2000 Follicle-stimulating hormone mediated calcium signaling by the alternatively spliced growth factor type I receptor. Biology of Reproduction 62 1067-1074. (doi:10.1095/biolreprod62.4.1067)
95. Vilodre LC, Kohek MB & Spritzer PM 2008 Screening of follicle-stimulating hormone receptor gene in women with premature ovarian failure in southern Brazil and associations with phenotype. Journal of Endocrino-logical Investigation 31 552-557. (doi:10.1007/BF03346407)
96. Virant-Klun I & Skutella T 2010 Stem cells in aged mammalian ovaries. Aging 2 3-6. (doi:10.1186/1757-2215-4-13)
97. Virant-Klun I, Skutella T, Hren M., Gruden K, Cvjeticanin B, Vogler A & Sinkovec J 2013 Isolation of small SSEA-4-positive putativestem cellsfrom the ovarian surface epithelium of adult human ovaries by two different methods. BioMed Research International 2013 690415. (doi:10.1155/2013/690415)
98. Vu Hai MT, Lescop P, Loosfelt H & Ghinea N 2004 Receptor-mediated transcytosis of follicle stimulating hormone through the rat testicular microvasculature. Biology of the Cell 96 133-144. (doi:10.1016/j.biolcel.2003.11.008)
99. Wang J, Lin L, Prakash V., Schwartz PE, Lauchlan SC & Zheng W 2003 Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. International Journal of Cancer 103 328-334. (doi:10.1002/ijc.10848)
100. Woad KJ, Prendergast D, Winship IM & Shelling AN 2013 FSH receptor gene variants are rarely associated with premature ovarian failure. Reproductive Biomedicine Online 26 396-399. (doi:10.1016/j.rbmo.2013.01.004)
101. Woods DC & Tilly JL 2013 Isolation, characterization and propagation of mitotically active germ cells from adult mouse and human ovaries. Nature Protocols 8 966-988. (doi:10.1038/nprot.2013.047)
102. Woods DC, White YA & Tilly JL 2013 Purification of oogonial stem cells from adult mouse and human ovaries: an assessment of the literature and a view toward the future. Reproductive Sciences 20 7-15. (doi:10.1177/1933719112462632)
103. Wright JW, Toth-Fejel S, Stouffer RL & Rodland KD 2002 Proliferation of rhesus ovarian surface epithelial cells in culture: lack of mitogenic response to steroid or gonadotropic hormones. Endocrinology 143 2198-2207. (doi:10.1210/endo.143.6.8848)
104. Xu J & Gridley T 2013 Notch2 is required in somatic cells for breakdown of ovarian germ-cell nests and formation of primordial follicles. BMC Biology 11 13. (doi:10.1186/1741-7007-11-13)
105. Yarney TA, Sairam MR, Khan H, Ravindranath N., Payne S & Seidah NG 1993 Molecular cloning and expression of the ovine testicular follicle stimulating hormone receptor. Molecular and Cellular Endocrinology 93 219-226. (doi:10.1016/0303-7207(93)90127-6)
106. Yarney TA, Jiang L, Khan H., MacDonald EA, Laird DW & Sairam MR 1997a Molecular cloning, structure, and expression of a testicular follitropin receptor with selective alteration in the carboxy terminus that affects signalling function. Molecular Reproduction and Development 48 458-470. (doi:10.1002/(SICI)1098-2795(199712)48:4<458::AID-MRD6>3.0.CO;2-P)
107. Yarney TA, Fahmy MH, Sairam M.R., Khan H & Macdonald EA 1997b Ontogeny of FSH receptor messenger ribonucleic acid transcripts in relation to FSH secretion and testicular function in sheep. Journal of Molecular Endocrinology 18 113-125. (doi:10.1677/jme.0.0180113)
108. Zhang XY, Chen J, Zheng Y.F., Gao XL, Kang Y, Liu JC, Cheng M.J., Sun H & Xu CJ 2009 Follicle-stimulating hormone peptide can facilitate paclitaxelnanoparticlesto target ovarian carcinoma in vivo. Cancer Research 69 6506-6514. (doi:10.1158/0008-5472.CAN-08-4721)
109. Zhang Z, Zhu Y, Lai Y., Wu X, Feng Z, Yu Y., Bast RC Jr, Wan X, Xi X & Feng Y 2013 Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway. International Journal of Oncology 43 1194-1204. (doi:10.3892/ijo.2013.2054)
110. Zheng W, Magid MS, Kramer EE & Chen YT 1996 Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. American Journal of Pathology 148 47-53. (doi:10.1006/gyno.1999.5628)
111. Zheng W, Lu JJ, Luo F, Zheng Y., Feng YJ, Felix JC, Lauchlan SC & Pike MC 2000 Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecologic Oncology 76 80-88. (doi:10.1006/gyno.1999.5628)